Measuring the Value of Patient Engagement to Demonstrate ROE to Stakeholders

Time: 9:00 am
day: Conference Day One


  • Exploring the challenges of quantifying and objectifying patient engagement for regulatory agencies and investors, focusing on the specific needs of regulatory bodies and investor communities
  • Discussing the role of investors in the biotech industry and the potential influence of patient advocacy in encouraging investment by quantifying community interest in treatment options
  • Emphasizing the need for a clear and standardized approach to quantify patient community interest, bridging the gap between patient advocacy and investor confidence in the biotech market